TY - JOUR
T1 - Phenylhydrazine as a partial model for β-thalassaemia red blood cell hemodynamic properties
AU - Ramot, Yuval
AU - Koshkaryev, Alexander
AU - Goldfarb, Ada
AU - Yedgar, Saul
AU - Barshtein, Gregory
PY - 2008/3
Y1 - 2008/3
N2 - β-Thalassaemia is a congenital haemoglobinopathy, associated with red blood cells (RBC) anomalies, leading to impairment of their flow-affecting properties, namely, RBC deformability, self-aggregability, and adherence to endothelial cells (EC). Treatment of normal RBC with phenylhydrazine (PHZ) causes selective association of oxidized α-globin chains with the membrane skeleton, leading to reduced RBC deformability, characteristic of β-thalassaemia. PHZ has thus been used to mimic phenotypes of β-thalassaemia RBC. The present study was undertaken to further elucidate the suitability of PHZ-treated RBC as a model for β-thalassemic RBC, by comparing the aggregability and adhesiveness of PHZ-treated RBC to those of RBC from thalassaemia intermedia (TI) patients, using image analysis of RBC under flow. In addition, the externalization of phosphatidylserine (PS), a mediator of RBC/EC interaction, was determined. It was found that PHZ caused enhanced RBC adhesiveness to extracellular matrix, similar to TI-RBC. Furthermore, in both conditions, the enhanced adhesiveness was mediated by PS translocated to the RBC surface. In contrast, PHZ treatment completely abolished RBC aggregability, while TI-RBC aggregability was slightly elevated. It is proposed that PHZ-treated RBC resemble β-thalassaemia RBC in their deformability and adhesiveness, but not in their aggregability, and thus can be used as a limited model for β-thalassaemia RBC phenotypes.
AB - β-Thalassaemia is a congenital haemoglobinopathy, associated with red blood cells (RBC) anomalies, leading to impairment of their flow-affecting properties, namely, RBC deformability, self-aggregability, and adherence to endothelial cells (EC). Treatment of normal RBC with phenylhydrazine (PHZ) causes selective association of oxidized α-globin chains with the membrane skeleton, leading to reduced RBC deformability, characteristic of β-thalassaemia. PHZ has thus been used to mimic phenotypes of β-thalassaemia RBC. The present study was undertaken to further elucidate the suitability of PHZ-treated RBC as a model for β-thalassemic RBC, by comparing the aggregability and adhesiveness of PHZ-treated RBC to those of RBC from thalassaemia intermedia (TI) patients, using image analysis of RBC under flow. In addition, the externalization of phosphatidylserine (PS), a mediator of RBC/EC interaction, was determined. It was found that PHZ caused enhanced RBC adhesiveness to extracellular matrix, similar to TI-RBC. Furthermore, in both conditions, the enhanced adhesiveness was mediated by PS translocated to the RBC surface. In contrast, PHZ treatment completely abolished RBC aggregability, while TI-RBC aggregability was slightly elevated. It is proposed that PHZ-treated RBC resemble β-thalassaemia RBC in their deformability and adhesiveness, but not in their aggregability, and thus can be used as a limited model for β-thalassaemia RBC phenotypes.
KW - Adherence
KW - Aggregation
KW - Phenylhydrazine
KW - Phosphatidylserine
KW - Thalassaemia
UR - http://www.scopus.com/inward/record.url?scp=39749110874&partnerID=8YFLogxK
U2 - 10.1111/j.1365-2141.2007.06976.x
DO - 10.1111/j.1365-2141.2007.06976.x
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 18302715
AN - SCOPUS:39749110874
SN - 0007-1048
VL - 140
SP - 692
EP - 700
JO - British Journal of Haematology
JF - British Journal of Haematology
IS - 6
ER -